Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
GJA1 Expression and Its Prognostic Value in Cervical Cancer
Silu Meng1, Xinran Fan1, Jianwei Zhang1
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Gap Junction Protein Alpha 1 (GJA1) is significantly lower in cervical cancer (CC) and indicates poor prognosis. High GJA1 expression correlates with advanced tumor features and altered immune cell abundance, suggesting its potential as a prognostic marker and therapeutic target in CC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gap Junction Protein Alpha 1 (GJA1) is a member of the gap junction family with known roles in various cancers.
- Understanding GJA1's specific function in cervical cancer (CC) is crucial for identifying new diagnostic and therapeutic strategies.
Purpose of the Study:
- To investigate the role of GJA1 expression in cervical cancer (CC).
- To evaluate GJA1 as a prognostic biomarker for CC patient survival.
- To explore signaling pathways and immune cell interactions associated with GJA1 expression in CC.
Main Methods:
- Utilized public data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.
- Analyzed GJA1 expression levels using GEPIA, GEO datasets, and Human Protein Atlas (HPA).
- Assessed correlations with clinicopathological features using chi-squared and logistic regression.
- Determined prognostic value via Kaplan-Meier and Cox regression analyses.
- Identified regulated pathways using Gene Set Enrichment Analysis (GSEA) and immune cell changes using ImmuCellAI.
Main Results:
- GJA1 expression was significantly lower in CC tissues compared to normal tissues.
- High GJA1 expression correlated with keratinization, hormone use, tumor size, and FIGO stage.
- Elevated GJA1 expression was an independent predictor of poor overall survival (HR=4.084, p=0.013).
- GSEA revealed enrichment of cancer-related pathways (e.g., p53, Wnt) in high GJA1 groups.
- Immune cell analysis showed increased abundance of CD8 naive T cells, dendritic cells, and neutrophils in high GJA1 groups.
Conclusions:
- GJA1 serves as a potential prognostic marker for poor survival in cervical cancer.
- GJA1 may represent a therapeutic target in CC, potentially through modulation of cancer-related pathways.
- GJA1 influences the tumor microenvironment by affecting immune cell abundance.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Survival Analysis
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

